En español
NIDA

HIV or AIDS

Drug and Alcohol Use - A Significant Risk Factor for HIV

From 2005 to 2009, 1 in 3 persons with HIV was a current drug user or binged on alcohol

On-site HIV testing increases life expectancy in substance abusers and is cost effective

An NIH-funded study shows that on-site rapid HIV testing has the potential to increases life expectancy for substance abuse treatment patients newly diagnosed with HIV in a cost effective way.


NIDA supports development of combined anti-heroin and HIV vaccine

Dr. Gary R. Matyas has been selected the 2012 recipient of the NIDA Avant-Garde Award for Medications Development.


Women and Sex/Gender Differences Research Program

NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

Blending conference translates substance abuse research into practice

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia.


NIDA Recognizes Developer of a New Business Model for Science

Dr. Redonna K. Chandler of NIDA receives the Institute's 2011 Innovator Award for developing a method that fosters collaboration and data sharing on various studies of HIV in criminal justice populations.

Pages

Subscribe to HIV or AIDS